← back to search

Ho Kyung Seo

National Cancer Center · KR
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Renal cell carcinoma treatment, and Prostate Cancer Diagnosis and Treatment.
h-index
27
citations
3,358
works
230
NIH funding
—
primary concept
Medicine
email
seohk@ncc.re.kr

Recent publications

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
The Lancet Oncology 2021cited by 525position: middledoi

Grants

Characterization and Optimization of Recombinant Cell Fermentatio Processes
NSF8707678$69,8011987–1990PIRePORTER

Frequent collaborators

Arjun Vasant Balar · NYU Langone Health1 papers (2021–2021)Hiroyuki Nishiyama · University of Tsukuba1 papers (2021–2021)Joost L. Boormans · Erasmus MC Cancer Institute1 papers (2021–2021)Haojie Li · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Laurence E. Krieger · Research Institute in Oncology and Hematology1 papers (2021–2021)Kijoeng Nam · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Tara L. Frenkl · GlaxoSmithKline (United States)1 papers (2021–2021)Eric A. Singer · Johnson University1 papers (2021–2021)Girish S. Kulkarni · University Health Network1 papers (2021–2021)Petros Grivas · Second Foundation (United States)1 papers (2021–2021)Edward Uchio · University of California, Irvine1 papers (2021–2021)Ashish M. Kamat · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)M. Roumiguié · International Union for Conservation of Nature (Bangladesh)1 papers (2021–2021)Ronald de Wit · Erasmus MC1 papers (2021–2021)Ekta Kapadia · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Badrinath R. Konety · University of Minnesota1 papers (2021–2021)Dean F. Bajorin · Kettering University1 papers (2021–2021)